Formulation Development

Formulation Development
Product Description

From preclinical and first-in-human (FIH) dosage forms to optimization of your drug product for late-stage development and market following clinical evaluation, we work with you to develop the most appropriate formulation based on the physicochemical and biopharmaceutics properties of your drug molecule, the intended route of administration and the phase of development. For more information visit: https://www.quotientsciences.com/services/formulation-development/

Read more Show less

Quotient Sciences

  • US
  • 2019
    On CPHI since
  • 4
    Certificates
  • 1000 - 4999
    Employees
Company types
Contract Service
View company profile
Categories
more categories Show less
Specifications
  • Supplied from
    United Kingdom; United States
More specifications Fewer specifications

Quotient Sciences

  • US
  • 2019
    On CPHI since
  • 4
    Certificates
  • 1000 - 4999
    Employees
Company types
Contract Service
View company profile

More Products from Quotient Sciences (2)

  • Translational Pharmaceutics

    Product Translational Pharmaceutics

    Translational Pharmaceutics®, accelerates development by integrating formulation development, real-time manufacturing and clinical testing.  This integrated approach is proven to reduce timelines by more than 12 months and lower R&D costs by more than $100 million.  Over the past decade ...
  • Drug Substance Synthesis and Manufacturing

    Product Drug Substance Synthesis and Manufacturing

    Quotient Sciences provides drug substance synthesis and manufacturing capabilities from candidate selection through to commercial production.  With tactical deployment of best-in-class technologies, we minimize chemistry costs and move your drug substance supply off the critical path. With more than 4...

Quotient Sciences resources (2)

  • Quotient Sciences expands service portfolio with Arcinova acquisition

    News Quotient Sciences expands service portfolio with Arcinova acquisition

    The acquisition will extend the 12-month drug development timeline savings already delivered by Quotient’s flagship platform Translational Pharmaceutics
    9 Feb 2021
  • Quotient Sciences Overview

    Video Quotient Sciences Overview

    Quotient Sciences is a drug development and manufacturing accelerator supporting customers across the entire development pathway from candidate selection to commercial launch. We deliver uniquely integrated programs and a range of tailored services that dramatically shorten drug development times. We’re driven by an unswerving belief that ideas need to become solutions, and molecules need to become cures, fast. Because humanity needs solutions, fast.
    2021-06-15